Emile Gogineni, MD

After growing up in the Greater Philadelphia Area, Emile Gogineni moved to Ann Arbor for his undergraduate studies, where he majored in music performance at the University of Michigan. After graduating, he moved to Washington DC, where he spent three years conducting basic science research in infectious disease and critical care labs at the National Institutes of Health, with a focus on mapping the Pneumocystis genome and on the development of a novel assay designed to test antibody levels in sera called LIPS.

During medical school, Dr. Gogineni developed an interest in oncology and pursued training in radiation oncology, which he completed at Northwell Health in New York. During residency, he conducted clinical research, producing over twenty publications, much of which focused on the use of stereotactic radiation in multiple subsites, including cancers of the head & neck, prostate, and pancreas, in addition to brain and spine metastases. He then joined Johns Hopkins University as an Instructor and Fellow, where he focused on proton irradiation.

He now serves as an Assistant Professor at The Ohio State University, where he focuses on head and neck cancers and proton therapy. In addition, he continues to conduct academic research related to particle therapy and stereotactic radiation, serving as the Principal Investigator on a trial studying hypofractionated preoperative proton therapy for soft tissue sarcoma. He functions as a Junior Faculty Advisor for the Radiosurgery Society, where he co-founded and co-leads a committee focusing on publishing case-based guidelines related to the use of stereotactic radiation for each oncologic subsite to guide clinicians while providing residents nationally and globally opportunities for mentorship. He also serves on the NRG Oncology Head & Neck and New Investigators Committees and the ACR Radiation Oncology Education Committee, where he leads the Webinar Initiative.

Keep up with Dr. Gogineni on Twitter: @EmileGogineni